In a statement, the U.S. Department of Justice stated, Gilead Sciences Inc has agreed to settle allegations that it improperly used the Caring Voice Coalition as a conduit to cover thousands of patients’ co-payment obligations and has agreed to pay… Read More ›
Gilead Sciences Inc
Drugmakers modestly hike U.S. drug prices
Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
Drugmaker Gilead Sciences Inc appoints Daniel O’Day as its CEO
Daniel O’Day is likely to joint Gilead Sciences sometime in 2019; a formal date has not been set. According to a source familiar with the matter at hand, Gilead Sciences Inc, a drugmaker, will appoint Roche Holding AG’s Daniel O’Day… Read More ›